ANAB financials
AnaptysBio (ANAB) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ANAB income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $234.60M | $232.18M | $47.90M | -$13.23M | -0.46 |
| 2024 | $91.28M | -$72.56M | -$114.95M | -$145.23M | -5.12 |
| 2023 | $17.16M | -$115.13M | -$164.41M | -$163.62M | -6.08 |
| 2022 | $10.29M | -$78.51M | -$115.15M | -$128.72M | -4.57 |
| 2021 | $63.17M | -$35.32M | -$56.81M | -$57.80M | -2.11 |
| 2020 | $75.00M | -$5.03M | -$23.88M | -$19.93M | -0.73 |
- ANAB revenue was $234.60M in fiscal 2025, net income -$13.23M.
Updated 2026-11-02 17:56 UTC